{"id":8414,"date":"2021-03-30T11:07:59","date_gmt":"2021-03-30T00:07:59","guid":{"rendered":"https:\/\/mvec.mcri.edu.au\/?p=8414"},"modified":"2021-03-30T11:07:59","modified_gmt":"2021-03-30T00:07:59","slug":"atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise","status":"publish","type":"post","link":"https:\/\/mvec.mcri.edu.au\/hi\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/","title":{"rendered":"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise"},"content":{"rendered":"<p>ATAGI have published recommendations for the vaccination of immune compromised patients with COVID-19 vaccines, Comirnaty\u2122 and COVID-19 AstraZeneca.<\/p>\n<p>COVID-19 vaccination is recommended for all immunocompromised people due to an increased risk of developing severe disease if infected with SARS-CoV-2. Administration of COVID-19 vaccines should be planned with the treating specialist and in some instances the timing of immune suppressive therapies may be altered to maximise immune responses to vaccination. Reducing the interval between COVID-19 vaccine doses to allow for planning of treatments can also be considered.<\/p>\n<p>\u0907\u0928 \u0938\u0941\u091d\u093e\u0935\u094b\u0902 \u0915\u094b \u0926\u0947\u0916\u0928\u0947 \u0915\u0947 \u0932\u093f\u090f \u0915\u0943\u092a\u092f\u093e \u0926\u0947\u0916\u0947\u0902<\/p>\n<ul>\n<li><a href=\"https:\/\/www.health.gov.au\/resources\/publications\/atagi-provider-guide-to-covid-19-vaccination-of-people-with-immunocompromise\" target=\"_blank\" rel=\"noopener\">ATAGI \u2013 Provider guide to COVID-19 vaccination of people with immunocompromise<\/a><\/li>\n<li><a href=\"https:\/\/www.health.gov.au\/resources\/publications\/atagi-covid-19-vaccination-decision-guide-for-people-with-immunocompromise\" target=\"_blank\" rel=\"noopener\">ATAGI \u2013 COVID-19 vaccination decision guide for people with immunocompromise<\/a><\/li>\n<\/ul>\n<p>For other information on the immunisation of immune compromised people please refer to:<\/p>\n<p><a href=\"https:\/\/mvec.mcri.edu.au\/references\/immunosuppression-and-vaccines\/\">\u090f\u092e\u0935\u0940\u0908\u0938\u0940: \u0907\u092e\u094d\u092f\u0942\u0928\u094b\u0938\u092a\u094d\u0930\u0947\u0936\u0928 \u0914\u0930 \u091f\u0940\u0915\u0947<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>COVID-19 vaccination is recommended for all immunocompromised people due to an increased risk of developing severe disease if infected with SARS-CoV-2. Administration of COVID-19 vaccines should be planned with the treating specialist and in some instances the timing of immune suppressive therapies may be altered to maximise immune responses to vaccination. Reducing the interval between COVID-19 vaccine doses to allow for planning of treatments can also be considered.<\/p>","protected":false},"author":375,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_lmt_disableupdate":"","_lmt_disable":"","footnotes":"","_wp_rev_ctl_limit":""},"categories":[87,8,10,61],"tags":[],"class_list":["post-8414","post","type-post","status-publish","format-standard","hentry","category-news","category-covid-19","category-external","category-immunisation-references"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ATAGI- COVID-19 vaccine guidance for patients with immunocompromise - The Melbourne Vaccine Education Centre (MVEC)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mvec.mcri.edu.au\/hi\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/\" \/>\n<meta property=\"og:locale\" content=\"hi_IN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise - The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"og:description\" content=\"COVID-19 vaccination is recommended for all immunocompromised people due to an increased risk of developing severe disease if infected with SARS-CoV-2. Administration of COVID-19 vaccines should be planned with the treating specialist and in some instances the timing of immune suppressive therapies may be altered to maximise immune responses to vaccination. Reducing the interval between COVID-19 vaccine doses to allow for planning of treatments can also be considered.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mvec.mcri.edu.au\/hi\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/\" \/>\n<meta property=\"og:site_name\" content=\"The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-30T00:07:59+00:00\" \/>\n<meta name=\"author\" content=\"Rachael McGuire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0926\u094d\u0935\u093e\u0930\u093e \u0932\u093f\u0916\u093f\u0924\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rachael McGuire\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0905\u0928\u0941\u092e\u093e\u0928\u093f\u0924 \u092a\u0922\u093c\u0928\u0947 \u0915\u093e \u0938\u092e\u092f\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u092e\u093f\u0928\u091f\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/\"},\"author\":{\"name\":\"Rachael McGuire\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/571925ba39f95adf6ba3463422a752d7\"},\"headline\":\"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise\",\"datePublished\":\"2021-03-30T00:07:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/\"},\"wordCount\":137,\"commentCount\":0,\"articleSection\":[\"Show all\",\"COVID-19\",\"External News\",\"Immunisation References\"],\"inLanguage\":\"hi-IN\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/\",\"name\":\"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise - The Melbourne Vaccine Education Centre (MVEC)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\"},\"datePublished\":\"2021-03-30T00:07:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/571925ba39f95adf6ba3463422a752d7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/#breadcrumb\"},\"inLanguage\":\"hi-IN\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\",\"name\":\"The Melbourne Vaccine Education Centre (MVEC)\",\"description\":\"Find all your vaccine related infos here.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"hi-IN\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/571925ba39f95adf6ba3463422a752d7\",\"name\":\"Rachael McGuire\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/hi\\\/author\\\/rachael-mcguire\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise - The Melbourne Vaccine Education Centre (MVEC)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mvec.mcri.edu.au\/hi\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/","og_locale":"hi_IN","og_type":"article","og_title":"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise - The Melbourne Vaccine Education Centre (MVEC)","og_description":"COVID-19 vaccination is recommended for all immunocompromised people due to an increased risk of developing severe disease if infected with SARS-CoV-2. Administration of COVID-19 vaccines should be planned with the treating specialist and in some instances the timing of immune suppressive therapies may be altered to maximise immune responses to vaccination. Reducing the interval between COVID-19 vaccine doses to allow for planning of treatments can also be considered.","og_url":"https:\/\/mvec.mcri.edu.au\/hi\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/","og_site_name":"The Melbourne Vaccine Education Centre (MVEC)","article_published_time":"2021-03-30T00:07:59+00:00","author":"Rachael McGuire","twitter_card":"summary_large_image","twitter_misc":{"\u0926\u094d\u0935\u093e\u0930\u093e \u0932\u093f\u0916\u093f\u0924":"Rachael McGuire","\u0905\u0928\u0941\u092e\u093e\u0928\u093f\u0924 \u092a\u0922\u093c\u0928\u0947 \u0915\u093e \u0938\u092e\u092f":"1 \u092e\u093f\u0928\u091f"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/#article","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/"},"author":{"name":"Rachael McGuire","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/571925ba39f95adf6ba3463422a752d7"},"headline":"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise","datePublished":"2021-03-30T00:07:59+00:00","mainEntityOfPage":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/"},"wordCount":137,"commentCount":0,"articleSection":["Show all","COVID-19","External News","Immunisation References"],"inLanguage":"hi-IN","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/","url":"https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/","name":"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise - The Melbourne Vaccine Education Centre (MVEC)","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/#website"},"datePublished":"2021-03-30T00:07:59+00:00","author":{"@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/571925ba39f95adf6ba3463422a752d7"},"breadcrumb":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/#breadcrumb"},"inLanguage":"hi-IN","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mvec.mcri.edu.au\/atagi-covid-19-vaccine-guidance-for-patients-with-immunocompromise\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mvec.mcri.edu.au\/"},{"@type":"ListItem","position":2,"name":"ATAGI- COVID-19 vaccine guidance for patients with immunocompromise"}]},{"@type":"WebSite","@id":"https:\/\/mvec.mcri.edu.au\/#website","url":"https:\/\/mvec.mcri.edu.au\/","name":"\u092e\u0947\u0932\u092c\u0930\u094d\u0928 \u0935\u0948\u0915\u094d\u0938\u0940\u0928 \u090f\u091c\u0941\u0915\u0947\u0936\u0928 \u0938\u0947\u0902\u091f\u0930 (\u090f\u092e\u0935\u0940\u0908\u0938\u0940)","description":"\u0905\u092a\u0928\u0947 \u091f\u0940\u0915\u0947 \u0938\u0947 \u0938\u0902\u092c\u0902\u0927\u093f\u0924 \u0938\u092d\u0940 \u091c\u093e\u0928\u0915\u093e\u0930\u0940 \u092f\u0939\u093e\u0901 \u092a\u094d\u0930\u093e\u092a\u094d\u0924 \u0915\u0930\u0947\u0902\u0964","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mvec.mcri.edu.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"hi-IN"},{"@type":"Person","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/571925ba39f95adf6ba3463422a752d7","name":"\u0930\u093e\u091a\u0947\u0932 \u092e\u0948\u0915\u0917\u093e\u092f\u0930","url":"https:\/\/mvec.mcri.edu.au\/hi\/author\/rachael-mcguire\/"}]}},"modified_by":"Rachael McGuire","_links":{"self":[{"href":"https:\/\/mvec.mcri.edu.au\/hi\/wp-json\/wp\/v2\/posts\/8414","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mvec.mcri.edu.au\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mvec.mcri.edu.au\/hi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/hi\/wp-json\/wp\/v2\/users\/375"}],"replies":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/hi\/wp-json\/wp\/v2\/comments?post=8414"}],"version-history":[{"count":0,"href":"https:\/\/mvec.mcri.edu.au\/hi\/wp-json\/wp\/v2\/posts\/8414\/revisions"}],"wp:attachment":[{"href":"https:\/\/mvec.mcri.edu.au\/hi\/wp-json\/wp\/v2\/media?parent=8414"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/hi\/wp-json\/wp\/v2\/categories?post=8414"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/hi\/wp-json\/wp\/v2\/tags?post=8414"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}